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ABSTRACT
Shortening of mRNA poly(A) tails (deadenylation) to trigger their decay is mediated mainly by the CCR4-NOT
deadenylase complex. While four catalytic subunits (CNOT6, 6L 7, and 8) have been identified in the
mammalian CCR4-NOT complex, their individual biological roles are not fully understood. In this study, we
addressed the contribution of CNOT7/8 to viability of primary mouse embryonic fibroblasts (MEFs). We found
that MEFs lacking CNOT7/8 expression [Cnot7/8-double knockout (dKO) MEFs] undergo cell death, whereas
MEFs lacking CNOT6/6L expression (Cnot6/6l-dKO MEFs) remain viable. Co-immunoprecipitation analyses
showed that CNOT6/6L are also absent from the CCR4-NOT complex in Cnot7/8-dKO MEFs. In contrast, either
CNOT7 or CNOT8 still interacts with other subunits in the CCR4-NOT complex in Cnot6/6l-dKO MEFs.
Exogenous expression of a CNOT7 mutant lacking catalytic activity in Cnot7/8-dKO MEFs cannot recover cell
viability, even though CNOT6/6L exists to some extent in the CCR4-NOT complex, confirming that CNOT7/8 is
essential for viability. Bulk poly(A) tail analysis revealed that mRNAs with longer poly(A) tails are more
numerous in Cnot7/8-dKO MEFs than in Cnot6/6l-dKO MEFs. Consistent with elongated poly(A) tails, more
mRNAs are upregulated and stabilized in Cnot7/8-dKOMEFs than in Cnot6/6l-dKOMEFs. Importantly, Cnot6/6l-
dKO mice are viable and grow normally to adulthood. Taken together, the CNOT7/8 catalytic subunits are
essential for deadenylation, which is necessary to maintain cell viability, whereas CNOT6/6L are not.
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Introduction
Regulation of mRNA decay in the cytoplasm is important for
proper gene expression, and its dysregulation causes various
disorders. Shortening of mRNA poly(A) tails by deadenyla-
tion is the initial, rate-limiting step in the exonucleolytic
mRNA decay pathway, which is also relevant to translational
suppression [1,2]. mRNA deadenylation occurs via two dis-
tinct steps. First, PAN2-PAN3 trims long poly(A) tails to ~110
nucleotides (nt) and subsequently, the CCR4-NOT complex
completes deadenylation [3,4].
Deadenylation activity of the CCR4-NOT complex was first
identified in yeast [5]. CCR4-NOT is a multi-protein complex,
consisting of at least eight core subunits (Ccr4p, Caf1p, Caf40p,
Caf130p, Not1p, Not2p, either Not3p or Not5p, and Not4p) in
yeast, and eight subunits (CNOT1, CNOT2, CNOT3, either
CNOT7 or CNOT8, either CNOT6 or CNOT6L, CNOT9,
CNOT10 and CNOT11) in mammals [6–8]. Consequently, in
mammals, there are four possible catalytic and six non-catalytic
subunits. The catalytic subunits include DEDD (Asp-Glu-Asp-
Asp) family proteins (CNOT7 and CNOT8) and exonuclease-
endonuclease-phosphatase (EEP) family proteins (CNOT6 and
CNOT6L). CNOT7/8 and CNOT6/6L are orthologs of yeast
Caf1p and Ccr4p, respectively, [6–9]. CNOT1, CNOT2, CNOT3,
CNOT9, CNOT10, and CNOT11 are non-catalytic subunits that
are involved in complex formation, regulation of catalytic activity,
and recruitment of the CCR4–NOT complex to target mRNAs
[10–17]. Structural analyses have revealed that CNOT1 is
a scaffold subunit responsible for assembly of the whole complex
[11,12,18]. When CNOT1 is suppressed in HeLa cells, expression
ofmost other subunits also decreases, resulting in severe reduction
of deadenylase activity [10]. Therefore, CNOT1 is critical not only
for assembly but also for maintenance of the CCR4–NOT com-
plex. A given CCR4-NOT complex includes either CNOT6 or
CNOT6L and either CNOT7 or CNOT8 [9,19]. CNOT1 binds
directly toCNOT7/8 through itsMIF4Gdomain [11,18]. CNOT7/
8 are required for incorporation of CNOT6/6L into the complex
via protein–protein interaction between CNOT7/8 and the leu-
cine-rich repeat (LRR) domain of CNOT6/6L [20].
The CCR4-NOT complex is critical to a variety of physiological
functions inmammals, including energymetabolism, B-cell devel-
opment, heart function, and liver maturation, via mRNA
deadenylation and subsequent degradation [14,21–23]. Mouse
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embryonic development also requires CCR4-NOT complex activ-
ity, asmice lacking theCnot1 orCnot3 genes (Cnot1-KOorCnot3-
KO mice, respectively) show embryonic lethality [14,22,24].
Furthermore, suppression of the complex leads to various forms
of cell death, such as apoptosis and necroptosis, indicating the
importance of mRNA decay in cell viability [10,21–23,25,26].
Several studies have described different roles of the catalytic
subunits in deadenylase activity and biological processes. While
an EEP family member, Ccr4p, is largely associated with dead-
enylase activity in yeast [5], DEDD family proteins, Ccf1 and
CNOT7/8, are critical in C. elegans and mammals, respectively,
[27,28]. Suppression ofCnot6l or bothCnot6/6l in human cancer
cell lines leads to proliferation arrest and cell death in
a deadenylase activity-dependent manner, indicating the impor-
tance of CNOT6/6L in mammals [26,29]. In the same study, it
was shown that CNOT6/6L and CNOT7/8 regulate distinct
groups of genes [26]. Therefore, CNOT6/6L and CNOT7/8
serve different functions, depending on cell types, biological
processes, and target genes. Importantly, recent studies show
that CNOT6/6L and CNOT7/8 display distinct biochemical
activities in deadenylation. These differences explain why two
different types of ribonuclease occur in a single complex [30,31].
The two paralogs, CNOT6/6L and CNOT7/8, in mammals have
been considered basically redundant. Cnot6l-KO or Cnot7-KO
mice are viable and normally grow to adulthood, supporting
their functional redundancy, at least in mouse embryonic devel-
opment and in embryo-to-adult viability [32–34]. On the other
hand, while CNOT7 andCNOT8 have overlapping roles in some
cases, as in growth of human breast cancer (MCF7) cells [35],
they also have unique roles in other contexts. For instance,
Cnot7-KOmice manifest defects in spermatogenesis that cannot
be compensated by CNOT8 [32,33]. To better understand the
different biological roles of the four catalytic subunits, further
analyses are necessary to clarify their distinctive functions in
various biological contexts.
In this study, we used primary MEFs prepared from mice
lacking CCR4-NOT complex subunits. Since Cnot1-KO, Cnot3-
KO, and Cnot8-KO mice are embryonically lethal (14, 22, 24 and
this study), we prepared MEFs from mice possessing conditional
alleles, in which loxP sequences were inserted, and we deleted the
corresponding targets using Cre-mediated somatic recombina-
tion. Given that primary MEFs lacking CCR4-NOT complex-
dependent deadenylation undergo cell death [25], roles of the
catalytic subunits in cell viability were investigated. We found
that CNOT7/8 is essential for viability of MEFs, whereas
CNOT6/6L are not. Gene expression analysis using RNA-
sequencing (RNA-seq) showed that upregulation and stabilization
of mRNAs weremore pronounced inCnot7/8-dKOMEFs than in
Cnot6/6l-dKO MEFs. Thus, we propose that CNOT7/8-, but not
CNOT6/6L-mediated mRNA decay regulates MEF viability and
that CNOT8 is required in mouse embryonic development.
Results
Cnot8-KO mice die in embryo, whereas Cnot6-KO mice
display no obvious abnormality
We generated Cnot6-KO and Cnot8-KO mice to examine phy-
siological roles of these subunits in mouse embryonic
development and to prepare primary MEFs. We inserted loxP
sequences and the neomycin-resistance gene cassette between
frt sequences into Cnot6 or Cnot8 gene loci in order to generate
either null or conditional alleles (Supplementary Fig. 1A).
Conditional alleles could be used to examine tissue-specific
roles in future studies. In KO alleles, exons 8 or 3 are removed
in the Cnot6 or Cnot8 genes, respectively. We found that
Cnot6-KO mice were born live at the predicted mendelian
frequency (Supplementary Fig. 1B). They grew to adulthood
and were fertile, at least under standard breeding conditions.
By crossing Cnot6-KO (generated in this study) and Cnot6l-KO
mice [34], Cnot6-KO/Cnot6l-heterozygous (Het) mice were
generated. Cnot6-KO/Cnot6l-Het mice were also normal and
fertile, although litter sizes in Cnot6-KO/Cnot6l-Het pairs were
slightly smaller than those of controls (Supplementary Fig. 1B).
Furthermore, Cnot6/6l-dKO mice were born at the predicted
mendelian frequencies and grew to adulthood. These data
indicate that CNOT6/6L are dispensable for mouse embryonic
development. Unexpectedly, Cnot8-KO mice died before
embryonic day 10.5 (Supplementary Fig. 1B), and CNOT7
could not compensate for the lack of CNOT8 during mouse
embryonic development.
Simultaneous suppression of Cnot7 and Cnot8 causes
marked cell death in MEFs
Based on embryonic phenotypes of mice lacking each catalytic
subunit in the CCR4-NOT complex, we prepared MEFs from
mice with Cnot8-flox alleles (Cnot8-flox MEFs) and subse-
quently deleted the Cnot8 gene with Cre-mediated recombina-
tion to generate Cnot8-KO MEFs. We employed recombinant
retrovirus to introduce Cre in MEFs. Cnot6-KO, Cnot6l-KO,
Cnot7-KO [32], and Cnot6/6l-dKO MEFs were prepared from
the corresponding KO mouse embryos. We also prepared
Cnot7-KO/Cnot8-flox MEFs by crossing Cnot7-Het/Cnot8-flox
pairs. Using Cre-mediated recombination, we generated Cnot7/
8-dKO MEFs. For controls, mock-infected MEFs were used.
MEFs were also prepared from mice with Cnot1-flox alleles
followed by Cre-mediated deletion of the Cnot1 gene (Cnot1-
KO MEFs). Immunoblot analysis confirmed that expression of
CNOT1 protein was substantially decreased (Fig. 1A, B).
CNOT1 protein was still detected after Cnot1 gene deletion
(Fig. 1A). We previously observed a similar result in Cnot3-KO
MEFs [25]. We speculate that cells which had comparably high
levels of CNOT1 protein before Cre-mediated gene deletion
survived until the time of our analysis, while cells with reduced
CNOT1 levels started to die. It is also possible that some cells
escaped gene deletion due to insufficient Cre expression, because
random integration of theCre gene into the host genome leads to
heterogeneous cell populations that vary in Cre expression.
Amounts of other subunits in the CCR4-NOT complex also
decreased in Cnot1-KOMEFs, resulting in decreased expression
of the whole complex, as shown by immunoprecipitation using
anti-CNOT3 antibody (Fig. 1A, B). Furthermore, the appearance
of floating cells and a significant increase in the number of
propidium iodide (PI)-incorporated cells indicated that Cnot1-
KOMEFs underwent cell death (Fig. 1C, D). Thereafter, we used
Cnot1-KO MEFs as positive controls, because they largely lack
the CCR4-NOT complex.
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We then examined viability of Cnot7/8-dKO and Cnot6/6l-
dKO MEFs. Cnot7/8-dKO MEFs underwent cell death, while
such outcomes were not observed in Cnot7-KO, Cnot8-KO, and
mock-infected MEFs (Fig. 2A, B and Supplementary Fig. 2).
There was no significant difference in PI-incorporated cells
among Cnot6-KO, Cnot6l-KO, Cnot6/6l-dKO, and wild-type
(WT) MEFs (Fig. 2A, B and Supplementary Fig. 2). Therefore,
as in the case of embryonic development, CNOT6/6L are dis-
pensable for cell viability. In contrast, CNOT7 and CNOT8 have
redundant functions in maintaining MEF viability.
Cnot7/8 suppression results in loss of catalytic subunits
from the CCR4-NOT complex
Decreased levels of intact CCR4-NOT complex result in
decreased MEF viability (25, and Fig. 1). We performed co-
immunoprecipitation experiments to examine the effects of
CNOT6/6L or CNOT7/8 suppression on complex formation.
CNOT8 protein was still detected after Cnot8 gene deletion
(Fig. 2C), probably for the same reasons described in the case
of Cnot1-KO MEFs (Fig. 1A, see above). Importantly, immu-
noprecipitation of lysates from Cnot7/8-dKO MEFs with anti-
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Figure 1. Cnot1-KO MEFs undergo cell death. (A) Lysates were prepared from Cnot1-flox MEFs that were infected with mock or Cre-expressing retrovirus and
subjected to immunoprecipitation with anti-CNOT3 antibody. CNOT3 are shown in red to indicate a precipitated molecule. Lysates and immunoprecipitates (IP) were
analysed by immunoblot with the indicated antibodies. (B) Quantification of the immunoblot data in Fig. 1A. Relative band intensities normalized to those of IP or
lysates in control MEFs are shown (n = 3). Values represent means ± standard error of the mean (S.E.M.). (C) Morphology of Cnot1-flox MEFs infected with mock
(Control) or Cre-expressing retrovirus (Cnot1-KO). Photographs are at the same magnification and represent one of the three independent experiments. Dead cells
that were about to lose adhesion were observed in Cnot1-KO MEFs. (D) Cell death was assessed by propidium iodide uptake using flow cytometry (n = 3). Values in
the graphs represent mean ± S.E.M. *P< 0.05, **P< 0.01, ***P< 0.001.
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CNOT3 antibody showed that levels of co-immunoprecipitated
CNOT6 and CNOT6L decreased substantially compared to
control MEFs (Fig. 2C and Supplementary Fig. 3A), indicating
that few catalytic subunits were associated with core subunits
(CNOT1-3) of the CCR4-NOT complex in Cnot7/8-dKO
MEFs. This is consistent with a study demonstrating CNOT7/
8 bridge interaction between CNOT6/6L and CNOT1 [20]. We
found that CNOT1, CNOT2, CNOT3, CNOT7, CNOT8,
CNOT9, and CNOT10 existed at similar levels in anti-
CNOT3 immunoprecipitates among WT, Cnot6-KO, Cnot6l-
KO and Cnot6/6l-dKO MEFs (Fig. 2D and Supplementary
Fig. 3B). These data suggest that loss of CNOT6/6L does not
affect association of other CCR4-NOT complex subunits.
CNOT7 catalytic activity is essential to maintain MEF
viability
MEFs without CNOT6/6L in the CCR4-NOT complex rarely
underwent cell death, indicating that CNOT7/8 are sufficient for
MEF viability (Fig. 2A, B). To examine whether CNOT7/8
catalytic activity is critically involved in MEF viability, we intro-
duced either FLAG epitope-tagged CNOT7-WT or CNOT7
mutants into Cnot7/8-dKO MEFs, using a recombinant retro-
virus. CNOT7 mutants used included a catalytically negative
mutant (CN) in which Asp40 and Glu42 were replaced with
Ala, and a dominant negative mutant (DN), which lacked both
catalytic activity and the capacity to bind CNOT6/6L (Cys67 and
Leu71 were replaced with Glu, in addition to the catalytically
negative mutation) [36].We first characterized CNOT7mutants
by overexpressing them in WT-MEFs. Results of immunopreci-
pitation with anti-FLAG antibody confirmed that CNOT7-WT
and CNOT7-CN, but not CNOT7-DN, interacted with CNOT6/
6L, whereas CNOT1, CNOT3 and CNOT9 were co-precipitated
with all CNOT7 constructs (Supplementary Fig. 4A). We found
that both CNOT7-CN and CNOT7-DN induced death in WT-
MEFs (Supplementary Fig. 4B), suggesting that these mutants
have a dominant negative effect onMEF viability. In the series of
complementation experiments, we used a recombinant adeno-
virus expressing Cre to delete the Cnot8 gene. When CNOT7-
WTwas reintroduced intoCnot7/8-dKOMEFs, cell viability was
comparable to that of control virus-infected MEFs (Fig. 3A, B).
Expression of either CNOT7-CN or CNOT7-DN failed to
recover viability, but further induced cell death (Fig. 3A, B).
This effect was likely caused by a dominant negative effect of
CNOT7-CN and CNOT7-DN as both mutants prevented endo-
genous CNOT8, residually expressed after Cre-mediated recom-
bination, from binding to CNOT1, leading to formation of
a non-functional complex. Immunoblot analyses revealed the
successful expression of FLAG-CNOT7-WT and mutants in
Cnot7/8-dKO MEFs (Fig. 3C, D). We found that the amount
of CNOT6/6L in anti-CNOT3 immunoprecipitates from Cnot7/
8-dKOMEFs expressing CNOT7-WT or CNOT7-CN increased
compared to that in Cnot7/8-dKO MEFs and those expressing
CNOT7-DN (Fig. 3C, D). These data suggest that the catalytic
activity of DEDD family proteins (CNOT7/8) in the CCR4-NOT
complex is essential for cell viability.
In addition, we examined whether exogenous overexpression
of CNOT6L can restore viability of Cnot7/8-dKO MEFs. The
results of cell death analysis showed that exogenous
overexpression of CNOT6L partly, but significantly, restored
viability of Cnot7/8-dKO MEFs (Supplementary Fig. 5A, B).
When we performed immunoprecipitation experiments, exo-
genously overexpressed CNOT6L existed in anti-CNOT3
immunoprecipitates (Supplementary Fig. 5C, D). This could
explain the recovery of viability. We speculate that residual
expression of CNOT8 enabled exogenously expressed
CNOT6L to exist in the CCR4-NOT complex.
Poly(A) tail length of bulk RNAs is elongated in
Cnot1-KO and Cnot7/8-dKO MEFs
We next compared deadenylase activity in Cnot1-KO, Cnot7/
8-dKO, and Cnot6/6l-dKO MEFs with their respective controls
(see Fig. 4 legend), and then examined poly(A) tail lengths of
bulk RNAs. In Cnot1-KO and Cnot7/8-dKO MEFs, the popula-
tion of mRNAs with poly(A) tail lengths longer than 50 nt
increased, while the population of mRNAs with poly(A) tail
lengths shorter than 50 nt decreased (Fig. 4A, B). On the other
hand, the distribution of poly(A) tail lengths was similar in
control and Cnot6/6l-dKO MEFs (Fig. 4C). We observed
a slight increase in the population of mRNAs with poly(A) tail
lengths between 50 and 100 nt (Fig. 4C), which is reminiscent of
what occurs in poly (A)-binding protein (PABP)-mediated pre-
vention of deadenylation, though the effect was smaller than in
human cancer cell lines [30]. These data suggest that deadenylase
activity is largely impaired in Cnot1-KO and Cnot7/8-dKO, but
not in Cnot6/6l-dKO MEFs.
Upregulation and stabilization of mRNAs in Cnot1-KO
and Cnot7/8-dKO MEFs compared to Cnot6/6l-dKO MEFs
To examine the effects of impaired deadenylation on global gene
expression, we performed total RNA-seq on Cnot1-KO, Cnot7/
8-dKO, Cnot6/6l-dKO MEFs and their respective controls (see
Methods). We found that 8257, 1344, and 710 mRNAs were
upregulatedmore than twofold inCnot1-KO,Cnot7/8-dKO, and
Cnot6/6l-dKOMEFs, respectively, compared with controls (Fig.
5A). The number of upregulatedmRNAs in Cnot7/8-dKOMEFs
was much smaller than that in Cnot1-KO MEFs. This can be
partly explained by residual expression of CNOT8 in Cnot7/
8-dKO MEFs (Fig. 2C). In addition, only a few mRNAs
decreased in Cnot1-KO MEFs, whereas 662 mRNAs decreased
in Cnot7/8-dKO MEFs when compared with their respective
controls (Fig. 5A). Similar results were observed in MCF7 [35].
These data suggest that CNOT7/8 have deadenylation-
independent, CNOT1-independent roles. The difference in
gene expression between control and Cnot6/6l-dKO MEFs was
less prominent (Fig. 5A).
We next assessed the stability of mRNAs based on the calcu-
lation of mRNA half-lives following actinomycin D (Act. D)
chase. The number of stabilized mRNAs was much greater
than that of destabilized mRNAs in both Cnot1-KO and
Cnot7/8-dKO MEFs (Fig. 5B). While around 2000 mRNAs
were stabilized in Cnot6/6l-dKO MEFs, a similar number of
mRNAs was destabilized (Fig. 5B). More than 70% of upregu-
lated mRNAs in Cnot7/8-dKO or Cnot6/6l-dKO MEFs over-
lapped with those in Cnot1-KO MEFs (Fig. 5C). Similar results
were observed in stabilized mRNAs (Fig. 5D). In contrast, less
RNA BIOLOGY 407
CNOT1
CNOT2
CNOT3
CNOT6
CNOT6L
CNOT7
(FLAG)
CNOT8
CNOT9
CNOT10
retro:
adeno: CreGFP
Mock WT DNCN
CreGFP
Mock WT DNCN
IP:anti-CNOT3 Lysates
retro:
adeno: CreGFP
Mock WT DNCN
Cre CreCre
Mock
10
20
30
0
40
D
ea
d 
ce
lls
 (%
)
A
C
BMock + GFP
CNOT7WT + Cre
Mock + Cre (Cnot7/8-dKO)
CNOT7CN + Cre
CNOT7DN + Cre
**
**
Cnot7-KO/Cnot8-flox MEFs
CNOT1
CNOT2 CNOT3
CNOT6 CNOT6L
CNOT7 (FLAG)
CNOT8 CNOT9
CNOT10
R
el
at
iv
e 
ba
nd
 in
te
ns
ity
IP Lysates
IP LysatesIP Lysates
IP Lysates
IP Lysates
IP Lysates
IP Lysates
IP Lysates
IP Lysates
1
0
1
0
1
0
1
0
1
0
1
0 0
1
0
1
0
1
** **
**
**
***
**
*** ***
**
***
** ** ** *** *** *** ***
***
* *
2
2
2
Mock + GFP
CNOT7WT + Cre
Mock + Cre (Cnot7/8-dKO)
CNOT7CN + Cre
CNOT7DN + Cre
***
D
Figure 3. CNOT7 catalytic activity is sufficient to maintain MEF viability. (A) Morphology of Cnot7-KO/Cnot8-flox MEFs infected with the indicated (retro + adeno)
viruses. (B) Cell death was assessed as in Fig. 1D (n = 3). (C) Lysates were prepared from Cnot7-KO/Cnot8-flox MEFs infected with the indicated viruses and subjected
to immunoprecipitation with anti-CNOT3 antibody. CNOT3 is shown in red to indicate a precipitated molecule. Lysates and IP were analysed by immunoblot. WT:
CNOT7 wild-type, CN: CNOT7 lacking catalytic activity, DN: CNOT7 dominant negative mutant which lacks catalytic activity and an ability to bind to CNOT6/6L. (D)
Quantification of the immunoblot data in Fig. 3C. Relative band intensities normalized to those of IP or lysates in control MEFs are shown (n = 3). Values represent
means ± S.E.M. *P< 0.05, **P< 0.01, ***P< 0.001.
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Figure 4. RNAs in Cnot1-KO and Cnot7/8-dKO MEFs have longer polyA tails compared to those in Cnot6/6l-dKO MEFs. (A-C) Poly(A) tail lengths of bulk RNA in Cnot1-
KO (A), Cnot7/8-dKO (B) and Cnot6/6l-dKO MEFs (C) (n = 2 for each genotype). Cnot1-flox MEFs infected with mock retrovirus, Cnot7+/+; Cnot8-flox MEFs infected with
mock retrovirus, and WT MEFs were used as controls, respectively. Densitograms of poly(A) tail lengths are shown below each image. The signal intensity normalized
to total intensity (%) was calculated. The mean of two independent experiments was used.
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than 50% of upregulated or stabilized mRNAs in Cnot7/8-dKO
were observed in Cnot6/6l-dKO MEFs (Fig. 5C, D). These data,
together with MEF viability data, suggest that the upregulated
and stabilized mRNAs common to both Cnot1-KO and Cnot7/
8-dKO, but not Cnot6/6l-dKO MEFs, are relevant to death of
MEFs. Gene ontology (GO) analysis indicated that stabilized
mRNAs overlapping between Cnot1-KO and Cnot7/8-dKO,
but not Cnot6/6l-dKO MEFs showed significant enrichment
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Figure 5. Gene expression and mRNA stability differ among Cnot1-KO, Cnot7/8-dKO and Cnot6/6l-dKO MEFs. RNA-seq analysis of Cnot1-KO, Cnot7/8-dKO and Cnot6/
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for molecules pertaining to ‘response to DNA damage
stimulus’ and ‘DNA damage repair’ (Supplementary Fig. 6 and
Supplementary Table 1).
Finally, we validated the results of RNA-seq by performing
quantitative PCR (qPCR) analysis. We first examined levels of
Foxo3 and Txnip mRNAs, which are stabilized in both Cnot1-
KO and Cnot7/8-dKO, but not Cnot6/6l-dKO MEFs in our
RNA-seq results (Fig. 5B). Foxo3 and Txnip mRNAs were
significantly upregulated in Cnot1-KO and Cnot7/8-dKO
MEFs, but not in Cnot6/6l-dKO MEFs, compared to controls
(Fig. 6A). We next assessed their stability using total RNAs
from Act. D-treated cells. Consistent with the results of RNA-
seq, both Foxo3 and Txnip mRNAs had significantly elon-
gated half-lives in Cnot1-KO and Cnot7/8-dKO MEFs, com-
pared to controls (Fig. 6B). Elongation of their half-lives was
less obvious in Cnot6/6l-dKO MEFs (Fig. 6B).
Discussion
Suppression of the CCR4-NOT complex causes severe defects in
cytoplasmic deadenylation and subsequent degradation of
mRNA [5–7]. Although many studies have addressed its
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Figure 6. Foxo3 and Txnip mRNAs are upregulated and stabilized in Cnot1-KO and Cnot7/8-dKO MEFs. (A) qPCR analysis of the indicated mRNAs in Cnot1-KO, Cnot7/
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function in various organisms, it was not clear whether its
different catalytic subunits serve distinct biological functions.
In this study, we showed that CNOT7/8, but not CNOT6/6L,
are essential for MEF viability. It is important to emphasize that
we evaluated the roles of the CCR4-NOT complex in normal
cells, by using primary fibroblasts with a low risk of mutation, in
contrast to cancer cell lines. The latter usually contain genetic
mutations that promote tumorigenesis, with the consequence
that malignant cells are governed by different molecular
mechanisms and signalling pathways than normal cells.
The decreased viability of Cnot7/8-dKO MEFs was conco-
mitant with a lack of all the catalytic subunits in the CCR4-
NOT complex (Fig. 2). While reintroduction of CNOT7-WT
in Cnot7/8-dKO MEFs recovered cell viability, expression of
CNOT7-CN and CNOT-DN mutants did not (Fig. 3), sug-
gesting that CNOT7 catalytic activity is critical in mainte-
nance of viability. Thus, a complex composed of CNOT6/6L,
catalytically inactive CNOT7, CNOT1 and other subunits fail
to function as an intact deadenylation complex for mainte-
nance of cell viability. We also found that overexpression of
CNOT6L in Cnot7/8-dKO MEFs rescued the cell death phe-
notype (Supplementary Fig. 5). However, in our Cnot7/8-dKO
MEFs, incomplete deletion of CNOT8 may have recruited
exogenously expressed CNOT6L to the complex, resulting in
enough deadenylase activity to maintain cell viability.
Whether CNOT6L overexpression can overcome the absence
of CNOT7/8 for cell viability remains unaddressed and will
require a different experimental system.
Gene expression profiling using RNA-seq revealed a larger
contribution of CNOT7/8 than CNOT6/6L in regulation of global
gene expression in MEFs. Similar results have been observed in
human cell lines, trypanosomes and Drosophila [35,37,38].
Remarkably, the catalytic effect of CNOT7/8 was more prominent
than that of CNOT6/6L, as is evident from the results of bulk
poly(A) tail analysis, which are clearly reflected in mRNA expres-
sion (26, 37 and this study). Absence of all known catalytic
subunits could explain, at least in part, the greater differences in
gene expression and mRNA stability in Cnot7/8-dKOMEFs than
in Cnot6/6l-dKO MEFs, as in cell viability. Although CNOT6/6L
are not part of the CCR4-NOT complex in Cnot7/8-dKO MEFs,
genes affected by Cnot6/6l-dKO were little represented in the set
of mRNAs affected by Cnot7/8-dKO. A similar observation was
reported in a previous study [26]. It is possible that CNOT6/6L
might be able to function independently of the complex to dead-
enylate mRNAs, because purified CNOT6/6L and CNOT7/8
exhibit deadenylase activity in vitro [17,39,40]. It would be intri-
guing to examine whether there are any biological contexts where
CNOT6/6L function independently in vivo.
While target mRNAs and biological processes vary by species
(human or mouse) or cellular status (transformed or non-
transformed), there seems to be a common mechanism by which
CNOT6/6L andCNOT7/8 regulate distinct groups ofmRNAs and
biological processes. In MCF7, CNOT7/8 is required for cell pro-
liferation, whereas CNOT6/6L are required for cell viability [26].
Furthermore, upon CNOT7/8 suppression, upregulated or stabi-
lized mRNAs showed limited overlap with those upregulated or
stabilized by CNOT6/6L suppression. A recently proposed model
of deadenylation considers the critical involvement of PABP on
mRNAs, suggesting distinct roles of CNOT6/6L and CNOT7/8.
Specifically, CNOT7/8 deadenylate PABP-free poly(A) tails until
they encounter PABP, and then CNOT6/6L take over,
removing PABP and subsequently deadenylating mRNAs
[30,31]. Importantly, PABP local availability varies according to
cell type and cell culture conditions [30]. This may explain, at least
in part, why CNOT6/6L and CNOT7/8 execute context-
dependent deadenylation. In S. cerevisiae, mRNAs have higher
Pab1 (PABP in yeast) occupancy and consequently, Ccr4p, rather
than Caf1p, contributes significantly to deadenylation [31].
Similarly, mRNAs are saturated with PABP in HeLa cells and are
deadenylatedmainly byCNOT6/6L [30]. Active translation state is
relevant to the abundance of PABPonmRNA.Binding of PABP to
mRNA is important for translation initiation and elongation,
because the translation initiation factor complex and PABP inter-
act on mRNAs to form closed-loop messenger ribonucleoprotein
complexes [41]. On the other hand, microRNA-mediated transla-
tional repression causes dissociation of PABP from mRNA, lead-
ing to mRNA degradation [42]. It is possible that CNOT6/6L or
CNOT7/8 preferentially target mRNAs which are translationally
active (abundant PABP) or silent (less PABP), respectively, result-
ing in different biological roles.Global analysis of translation status
in MEFs or mouse embryos using ribosome profiling should be
useful to determine whether CNOT6/6L and CNOT7/8 activities
are dependent on the mRNA translation status.
Several lines of evidence show that in addition to its function
as a deadenylase, the CCR4-NOT complex has nuclear roles in
transcription and mRNA export [8]. In S. cerevisiae, the CCR4-
NOT complex interacts with TATA-binding protein (TBP) and
TBP-associated factor (TAF) to suppress transcription initia-
tion [43,44]. On the other hand, it stimulates transcription
elongation through its association with RNA polymerase II
complexes [45]. Moreover, the CCR4-NOT complex is involved
in transcriptional regulation in mammals [24,32,46–49]. We
previously showed that dysregulation of transcriptional mechan-
isms occurs in liver development and adipocyte homoeostasis
upon suppression of CNOT3 or CNOT1 [23,50]. In this study,
not all upregulatedmRNAs inCnot1-KOMEFs can be explained
on the basis of mRNA stabilization (Fig. 5). These data suggest
that suppression of transcription and other nuclear roles of the
CCR4-NOT complex could be responsible for upregulation of
a subset of genes. We hypothesize that the decrease of
a significant number of mRNA species in Cnot7/8-dKO is pos-
sibly due to loss of the catalytic activity-independent function of
CNOT7/8, which positively affects transcription. Indeed,
CNOT7/8 upregulate transcription mediated by the nuclear
receptors, ERα and RARβ [32,51,52].
We did not observe any obvious abnormalities in mouse
embryonic development, growth to adulthood, or MEF viabi-
lity in the absence of CNOT6/6L, suggesting that CNOT6/6L
do not target mRNAs encoding molecules involved in those
processes. It is also possible that CNOT7/8-mediated dead-
enylation is sufficient to regulate mRNAs in those processes,
because CNOT7/8 could deadenylate PABP-bound mRNAs,
albeit with low efficiency [30]. Yet, CNOT6/6L-mediated
mRNA decay is still central to certain biological events. For
example, CNOT6/6L are critical to survival of MCF7 [26]. In
NIH3T3 mouse fibroblasts, knockdown of CNOT6L causes
a severe reduction in proliferation, concomitant with signifi-
cant stabilization of p27kip1 mRNA [29]. We found that
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mRNAs encoding molecules involved in cell proliferation
were enriched among stabilized mRNAs in Cnot6/6l-dKO
MEFs. Therefore, CNOT6/6L are likely to regulate prolifera-
tion of fibroblasts without affecting viability. Furthermore,
Cnot6l-KO mice exhibit resistance to diet-induced obesity,
enhanced energy expenditure, and improved insulin sensitiv-
ity [34].
While both Cnot7-KO and Cnot8-KOMEFs are viable, Cnot7/
8-dKO MEFs undergo death. This is consistent with functional
redundancy of CNOT7 and CNOT8, owing to their high amino
acid sequence similarity [35]. In this study, we found that Cnot8-
KOmice die in embryo. A specific developmental role of CNOT8
is also observed in zebrafish [53]. Attenuation of Cnot8 in zebra-
fish caused upregulation of developmental control genes and early
lethality [53]. Reciprocally, Cnot7-KO male mice have defects in
spermatogenesis, even in the presence of CNOT8 [32,33].
Together, despite the functional redundancy of CNOT7 and
CNOT8 in some contexts, as in MEFs (in this study) and MCF7
cells [35], they play distinct roles [32,33,53]. Differential expres-
sion of CNOT7 and CNOT8 could be relevant to their specific
roles, as previously reported in mouse neural tissues [54].
Furthermore, SMG5/7 proteins, which function in nonsense-
mediated mRNA decay (NMD), preferentially interact with
CNOT8 rather than CNOT7 [55], suggesting different biological
roles. Importantly, NMD is essential for embryonic development
and viability [56]. On the other hand, we cannot exclude the
possibility that CNOT8 functions in zebrafish or mouse embryo-
nic development independently of its catalytic activity in the
CCR4-NOT complex. Further analyses are necessary to address
the molecular basis for the distinctive functions of CNOT7 and
CNOT8.
Our data suggest that maintenance of cell viability is one of
the fundamental roles of the CCR4-NOT complex, which is
mediated mainly by the catalytic activity of the CNOT7/8.
Their vital importance in regulating global mRNA expression
is clearly reflected in our RNA-seq results. On the other hand,
CNOT6/6L are dispensable in embryonic development and
for MEF viability. However, relatively few biological processes
have been examined to date. Mouse strains generated with
null or conditional alleles for catalytic subunits of the CCR4-
NOT complex are valuable tools to analyse functions of each
catalytic subunit in various tissues and biological contexts.
Methods
Mice
Cnot6 and Cnot8 conditional mice (Accession No. CDB0794K
and CDB0584K: http://www2.clst.riken.jp/arg/mutant%20mice%
20list.html) were generated with TT2 ES cell lines as described
previously (http://www2.clst.riken.jp/arg/Methods.html). To gen-
erate conditional alleles (floxed alleles) or KO alleles (null alleles)
for targeted alleles, mice with targeted alleles were crossed with
mice expressing FLP (Jackson #009086) or those expressing Cre
under control of the CAG promoter (CAG-Cre mice) [57],
respectively. Primers for genotyping PCR are listed in
Supplementary Table 2. The absence of FLP knock-in alleles in
mice with floxed alleles was also confirmed by PCR. Cnot1-flox
and Cnot8-flox represent Cnot1loxP/loxP and Cnot8loxP/loxP,
respectively. While Cnot1-KO and Cnot8-KO mice represent
null alleles, Cnot1-KO and Cnot8-KO MEFs represent Cnot1-
flox and Cnot8-flox MEFs, together with Cre expression. Cnot6-
KO, Cnot6l-KO, and Cnot7-KO represent null alleles (Cnot6−/-,
Cnot6l−/-, and Cnot7−/-). Cnot6l-KO and Cnot7-KO mice have
been described previously [32,34]. Note that we removed the β-
galactosidase-neomycin cassette in the Cnot6l-KO allele [32] by
crossing with CAG-Cre mice. We backcrossed these mouse
strains with C57BL/6J mice for at least eight generations. Mice
were maintained on a 12 h light/dark cycle in a temperature-
controlled (22°C) barrier facility with free access to water and
a normal diet (NCD, CA-1, CLEA Japan, Inc.). Mouse experi-
ments were approved by the Animal Care and Use Committee in
Okinawa Institute of Science and Technology Graduate
University, and by Institutional Animal Care and Use
Committee in RIKEN Kobe Branch.
Cell culture
MEFs were prepared as described previously [25] and were
cultured at 37°C in Dulbecco’s modified Eagle’s medium
supplemented with 10% foetal bovine serum. We used Cnot1-
flox MEFs infected with mock retrovirus and Cnot7+/+; Cnot8-
flox MEFs (littermates of Cnot7-KO; Cnot8-flox MEFs)
infected with mock retrovirus, as controls for Cnot1-KO and
Cnot7/8-dKO MEFs, respectively. We used WT MEFs with
the same passage number as controls for Cnot6/6l-dKO MEFs.
Antibodies
Rabbit polyclonal antibodies against CNOT1 (14,276-1-AP)
and CNOT2 (34,214) were purchased from Proteintech and
Cell Signalling Technology, respectively. Mouse monoclonal
antibodies against CNOT3, CNOT6L, and CNOT8 were gen-
erated by immunizing mice in cooperation with Bio Matrix
Research Incorporation [25]. A mouse monoclonal antibody
against CNOT6 was raised against a recombinant Autographa
californica multiple nuclear polyhedrosis virus displaying
a fusion protein containing amino acids 141–190 of human
CNOT6, as previously described [58]. Mouse polyclonal anti-
body against CNOT7 (H00029883-M01) was obtained from
Abnova. Antibody against CNOT10 (A304-899A) was from
Bethyl Laboratories.
Virus infection
Infection of MEFs with retrovirus (mock or Cre) was per-
formed as described previously [59]. Retroviruses (mock and
Cre) were produced by transfecting Plat-E packaging cells
with 2 μg empty pMX-puro plasmid or 2 μg pMX-puro-Cre
plasmid [25] using TransIT-LT1 transfection reagent
(Takara). Two days after transfection, cell culture superna-
tants containing the retroviruses were filtered (MILLEX GV
0.22 μm, Millipore) and polybrene (0.5 μg/mL, Sigma) was
added. The resultant viral solutions were used for infection of
MEFs that were seeded at 8.5 × 105 cells per 10 cm dish
the day before infection. Two days after retroviral infection,
cells were diluted following trypsinization and cultured in the
presence of puromycin (1 µg/mL) for additional 2 days to
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select infected cell populations and subsequently used for
analyses. In the series of rescue experiments: CNOT7-WT,
CNOT7-mutants (from T. Fujiwara) and CNOT6L [29]
cDNA fragments were inserted into pMX-vectors and used
for retrovirus production and subsequent infection to MEFs.
Adenovirus infection [control (GFP) and Cre] was performed
2 days after retrovirus infection at MOI 7.5. Two days later,
adenovirus-infected MEFs were used for immunoprecipita-
tion. For cell death analysis, MEFs were cultured in the pre-
sence of puromycin (1 µg/mL) for additional 2 days.
Immunoprecipitation and immunoblotting
MEFs were lysed with TNE lysis buffer (1% NP-40, 50 mM
Tris–HCl [pH 7.5], 150 mM NaCl, 1 mM EDTA, 1 mM
phenylmethylsulfonylfluoride, and 10 mM NaF). We used
5% of each lysate for an expression check (lysate lanes). The
remainder of each lysate was incubated with anti-CNOT3
antibody for 1 h at 4°C with rotation, followed by incubation
with Protein G Sepharose (GE Healthcare) for 2 h at 4°C with
rotation. Half (one-fifth only in Supplementary Fig. 5) of each
immunoprecipitated product was loaded per lane and ana-
lysed by immunoblot, as described previously [25].
Measurement of cell survival rate
Cell viability was measured by the ability of cells to exclude
propidium iodide (PI). Cells were treated with 0.1% trypsin,
collected by centrifugation, washed once with phosphate-
buffered saline (PBS), and resuspended in PBS containing 5
μg/mL of PI (Sigma). Levels of PI incorporation were quanti-
fied using a FACS Calibur (Becton Dickinson).
RNA analysis
Total RNA was extracted with Isogen II, according to the
manufacturer’s protocol (Nippon Gene). To measure mRNA
stability, we treated cells with actinomycin D (2.5 μg/mL) 4
days after viral infection, including the 2 days of puromycin
selection (see virus infection above). Total RNA was extracted
at 0, 4 and 8 h after addition of actinomycin D. RNA purity
and concentration were evaluated by spectrophotometry using
a NanoDrop ND-2000 (ThermoFisher). Total RNA (1 μg) was
used for reverse transcription with oligo(dT)12-18primer
(Invitrogen) using the SuperScript III First-Strand Synthesis
System (Invitrogen). qPCR reactions were carried out using
TB Green Premix Ex Taq (Takara) and the ViiA 7 Real-Time
PCR System (Applied Biosystems). Gapdh mRNA levels were
used for normalization. Relative mRNA expression was deter-
mined by the ΔΔCT method. Primers for qPCR reactions are
listed in Supplementary Table 2.
RNA sequencing
The quality of RNA was assessed using the Agilent 2100
Bioanalyzer microfluidics-based platform (Agilent
Technologies, Inc.). The RNA Integrity Number (RIN) was
over 9.0 in all samples. RNA-seq was performed by the DNA
Sequencing Section at Okinawa Institute of Science and
Technology Graduate University for two biological replicates
per condition. One hundred nano grams of total RNA were
used for RNA-seq library preparation with a TruSeq Stranded
mRNA Library Prep Kit for NeoPrep (NP-202-1001,
Illumina), which allows polyA-oligo(dT)-based purification
of mRNA, according to the manufacturer’s protocol, with
minor modifications and optimization as follows. Custom
dual index adaptors were ligated at the 5ʹ and 3ʹ-ends of the
library, and PCR was performed for 11 cycles. 150-base-pair
pair-end read RNA-seq was performed using a Hiseq 3000/
4000 PE Cluster Kit (PE-410-1001; Illumina) and a Hiseq
3000/4000 SBS Kit (300 Cycles) (FC-410-1003; Illumina) on
a Hiseq4000 (Illumina), according to the manufacturer’s pro-
tocol. Sequence data are available through ArrayExpress
under the accession number [E-MTAB-8287].
RNA-sequencing data analysis
Paired-end RNA-seq data were mapped to the Mus musculus
reference strain mm10 UCSC using Strand NGS software
(Strand Genomics). Transcript abundance for each replicate
was measured in Fragments Per Kilobase Mapped (FPKM).
Genes with FPKM < 0.1 were removed, and only ‘protein-
coding genes’ were considered. For comparison, we used gene
expression values defined as Gene FPKMs normalized with
Gapdh FPKM. Fold changes in gene expression values (KO
against control MEFs) were determined. Half-lives were cal-
culated based on the decay rate of each transcript after sup-
pression of transcription. Total RNA was prepared at 0, 4, and
8 h after Act. D treatment, and subjected to RNA-seq. To
calculate the mRNA degradation rate constant (kdegradation),
gene expression values were plotted on a semilogarithmic
scale as a function of time (t). The line that best fit the data
was identified using linear regression, then kdegradationwas
obtained from the slope. The t1/2 was calculated by substitu-
tion in the equation:
t1=2 ¼ ln 2ð Þ=kdegradation
mRNAs having half-lives less than 0 h or more than 50 h were
excluded as unreliable. Cnot1-flox or Cnot7+/+/Cnot8-flox MEFs
infected with mock virus were used as controls for Cnot1-KO
and Cnot7/8-dKO MEFs, respectively. WT MEFs were used as
controls for Cnot6/6l-dKO MEFs. mRNAs having more than
twofold longer half-lives compared to controls were considered
stabilized genes. GO enrichment analysis was performed with
DAVID Bioinformatics Resources 6.8 (https://david.ncifcrf.gov).
Bulk poly(A) tail assay
We confirmed that RINs were over 9.0 in all samples using the
Agilent 2100 Bioanalyzer microfluidics-based platform. Total
RNA (10 µg) was labelled with [5′-32P] pCp (cytidine 3′,5′-bis
[phosphate]) (0.11 pmol/μL in a total reaction volume of 30 μL)
(PerkinElmer; NEG019A) using T4 RNA ligase 1 (NEB, M0204S)
at 16°C overnight. Labelled RNAs were incubated at 85°C for 5
min and placed on ice. Then, labelled RNAs were digested with
Ribonuclease A (50 ng/μL, Sigma) and Ribonuclease T1 (1.25 U/
μl, ThermoFisher Scientific) at 37°C for 2 h in digestion buffer
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(100 mM Tris-HCl [pH7.5], 3M NaCl, 0.5 μg/mL yeast tRNA).
Reactions were stopped by adding 5x stop solution (10 mg/mL
Proteinase K, 0.125 M EDTA, 2.5% SDS) and subsequently incu-
bating at 37°C for 30 min. After adding 400 μL of RNA precipita-
tion buffer (0.5 M NH4OAc, 10 mM EDTA), digested RNA
samples were purified by phenol-chloroform extraction and iso-
propanol precipitation. Final products (10 μL) were mixed with
RNA Gel loading Dye (NEB, R0641) and incubated at 95°C for 2
min. Then, samples were fractionated on 8 M urea-10% poly-
acrylamide denaturing gels (0.8 mm thick). Markers (Prestained
Markers for small RNA Plus, BioDynamics Laboratory DM253)
were also loaded. The gel was analysed using a Typhoon FLA 9500
Fluorescence Imager (GE Healthcare). Band intensity was quan-
tified using Image J.
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